Table 2 Characteristics of prostate cancer cases and controls included in association study
From: Carboxypeptidase 4 gene variants and early-onset intermediate-to-high risk prostate cancer
Cases (N = 506) | Controls (N = 506) | |
|---|---|---|
Age (mean ± SD) | 65.7 ± 8.2 | 65.6 ± 8.3 |
Ethnicity n (%) | ||
African-American | 89 (18) | 89 (18) |
Caucasian | 417 (82) | 417 (82) |
Institution n (%) | ||
Cleveland Clinic Foundation | 407 (80) | 407 (80) |
University Hospitals, Cleveland | 99 (20) | 99 (20) |
Family history of prostate cancer n (%) | ||
Yes* | 31 (6) | 7 (1) |
No | 475 (94) | 499 (99) |
Tumor Stage† n (%) | ||
T1 | 305 (60) | NA |
T2 | 145 (29) | NA |
T3 | 30 (6) | NA |
Gleason Score n (%) | ||
5 | 3 (1) | NA |
6 | 79 (16) | NA |
7 | 314 (62) | NA |
8 | 67 (13) | NA |
9 | 39 (8) | NA |
10 | 4 (1) | NA |
PSA ng/ml (mean ± SD) | 14.1 ± 27.4 | 1.7 ± 1.7 |